Athira Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Athira Pharma, Inc. (ATHA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents48.44147.4295.97253.76184.68
Short-Term Investments2.8456.84104.38143.22124.06
Cash & Short-Term Investments51.28147.42200.34253.76184.68
Accounts Receivable0.001.601.232.341.30
Inventory0.000.000.000.000.00
Other Current Assets3.573.115.960.72-0.64
Total Current Assets54.84154.73207.53260.80192.34
Non-Current Assets
Property, Plant & Equipment (Net)3.254.445.325.223.59
Long-Term Investments0.630.0044.8365.9483.51
Other Non-Current Assets0.691.080.480.060.13
Total Non-Current Assets3.945.5250.6273.5588.53
Total Assets58.78160.25258.15332.01279.56
Current Liabilities
Accounts Payable0.3228.472.509.004.28
Short-Term Debt0.410.000.000.000.00
Accrued Liabilities12.4028.3415.196.533.12
Other Current Liabilities12.404.553.421.911.62
Total Current Liabilities13.1428.8421.439.294.41
Non-Current Liabilities
Long-Term Debt0.801.221.591.630.88
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.801.221.591.630.88
Total Liabilities13.9430.0623.0210.925.28
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-406.15-309.56-191.53-96.28-41.01
Accumulated Other Comprehensive Income0.00-0.35-1.96-0.390.03
Additional Paid-in Capital450.98439.74428.62417.36315.29
Shares Outstanding3.903.823.793.740.00
Total Stockholders' Equity44.84130.19235.14321.08274.28
Total Liabilities & Equity58.78160.25258.15332.01279.56